Recce Pharmaceuticals Ltd Receives New Patent in Israel for Recce Anti-Infectives
In 2021, Israel?s pharmaceutical market reached $5.3 billion, spending 8.3% of GDP on healthcare in 2020,1 up from 6.8% in 2000,
placing Israel as one of the fastest healthcare spending growth countries. The Central Bureau of Statistics has predicted that the elderly population in Israel will increase by 77%, accounting for 14.3% of the population by 2040. As a result, it is estimated that the Israeli pharmaceutical market will see growth on the back of the aging population due to the increasing burden of chronic diseases. Bacterial Pathogens Covered in Family 4 Specific examples of bacterial infections consist of Proteus spp, Serratia spp, Pseudomonas aeruginosa, Neisseria meningitidis, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, coagulase-negative Staphylococcus spp, Streptococcus pyogenes, Streptococcus pneumoniae and Enterococcusspp. Viral Pathogens Covered in Family 4: Examples of viral infections include those caused by a range of viruses, including coated viruses (e.g., lipid-coated viruses) such as herpes, HIV, cytomegalovirus, and influenza. The viral infection treated and/or controlled by the method of the invention may be HSV-1, HSV-2, Varicella Zoster Virus (in the form of chicken pox or shingles), HCMV, EBV, herpes 6, herpes 7, herpes 8, and SARS-CoV-2. Other examples include influenza A,Ross River virus, and coronaviruses, including those responsible for severe acute respiratory syndrome and SARS-CoV-2 (COVID-19).